Astragalus extract inhibits destruction of gastric cancer cells to mesothelial cells by anti-apoptosis

doi:10.3748/wjg.15.570

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 5

This Article

(0)

(6064)

(41)

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Original Article

World J Gastroenterol. Feb 7, 2009; 15(5): 570-577
Published online Feb 7, 2009. doi: 10.3748/wjg.15.570

Full Size Figure Download Figure

Figure 3 Viability of mesothelial cells after treatment with SF-CM and Astragalus injection. Mesothelial cells (5 × 10³ cells/well) were treated with SF-CM, 200 &mgr;g Astragalus injection, and SF-CM plus 200 &mgr;g Astragalus injection for 12, 24 and 48 h, respectively. Mesothelial cells cultured in serum free DMEM served as controls. MTT assays were performed in triplicate for each data point.

Citation: Na D, Liu FN, Miao ZF, Du ZM, Xu HM. Astragalus extract inhibits destruction of gastric cancer cells to mesothelial cells by anti-apoptosis. World J Gastroenterol 2009; 15(5): 570-577
URL: https://www.wjgnet.com/1007-9327/full/v15/i5/570.htm
DOI: https://dx.doi.org/10.3748/wjg.15.570

Na D, Liu FN, Miao ZF, Du ZM, Xu HM. Astragalus extract inhibits destruction of gastric cancer cells to mesothelial cells by anti-apoptosis. World J Gastroenterol 2009; 15(5): 570-577 [PMID: 19195058 DOI: 10.3748/wjg.15.570]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.